Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

NCT06714591

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

NCT07091019

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stockton Hematology Oncology Medical Group Inc Stockton, California, United States
  • Lundquist Inst BioMed at Harbor Torrance, California, United States
  • Stamford Hospital Stamford, Connecticut, United States
View all 17 locations
View Trial Details
Recruiting

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

NCT07205315

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +31 more
Locations
  • Zhengzhou Yihe Hospital Zhengzhou, Henan, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

NCT06136559

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • USA Mitchell Cancer Institute ( Site 0014) Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center ( Site 0059) Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0051) Phoenix, Arizona, United States
  • Arizona Oncology Associates - NAHOA ( Site 8007) Prescott, Arizona, United States
View all 200 locations
View Trial Details
Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

NCT07155226

Conditions
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Bone Marrow Diseases, +15 more
Locations
  • Research Site Decatur, Illinois, United States
  • Research Site New York, United States
  • Research Site Chapel Hill, North Carolina, United States
  • Research Site Durham, North Carolina, United States
View all 30 locations
View Trial Details
Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

NCT05886049

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation, +8 more
Locations
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
View all 22 locations
View Trial Details

Related conditions